Douglass Winthrop Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,392
Closed -$419K 242
2018
Q4
$419K Hold
1,392
0.02% 175
2018
Q3
$492K Hold
1,392
0.02% 169
2018
Q2
$404K Buy
1,392
+75
+6% +$21.1K 0.02% 213
2018
Q1
$361K Sell
1,317
-1,233
-48% -$383K 0.02% 214
2017
Q4
$812K Hold
2,550
0.04% 140
2017
Q3
$798K Hold
2,550
0.05% 136
2017
Q2
$692K Hold
2,550
0.04% 143
2017
Q1
$697K Hold
2,550
0.04% 139
2016
Q4
$723K Hold
2,550
0.05% 132
2016
Q3
$798K Sell
2,550
-200
-7% -$59.2K 0.06% 129
2016
Q2
$665K Sell
2,750
-100
-4% -$26.4K 0.05% 141
2016
Q1
$742K Hold
2,850
0.05% 132
2015
Q4
$873K Hold
2,850
0.06% 126
2015
Q3
$832K Sell
2,850
-50
-2% -$16.5K 0.07% 132
2015
Q2
$1.22M Hold
2,900
0.1% 108
2015
Q1
$1.22M Sell
2,900
-132
-4% -$52K 0.1% 108
2014
Q4
$1.03M Buy
3,032
+53
+2% +$17.1K 0.09% 96
2014
Q3
$985K Buy
2,979
+29
+1% +$9.56K 0.09% 93
2014
Q2
$930K Hold
2,950
0.09% 97
2014
Q1
$902K Hold
2,950
0.09% 93
2013
Q4
$825K Hold
2,950
0.09% 94
2013
Q3
$710K Hold
2,950
0.08% 93
2013
Q2
$635K Buy
+2,950
New +$630K 0.08% 98

Other funds holding BIIB

Douglass Winthrop Advisors's BIIB Position: Q1 2019 in Review

Douglass Winthrop Advisors sold out of Biogen (BIIB) in Q1 2019, closing a stake of 1,392 shares — an estimated $419K sold.

Douglass Winthrop Advisors first reported a position in BIIB in Q2 2013 and held it in 23 quarters. The position peaked at $1.22M in Q2 2015. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Douglass Winthrop Advisors reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Douglass Winthrop Advisors sold 1,392 Biogen shares in Q1 2019, an estimated $419K.
  • Douglass Winthrop Advisors first reported a position in Biogen in Q2 2013 and held it in 23 quarters.
  • Douglass Winthrop Advisors's Biogen position peaked at $1.22M in Q2 2015.
  • 1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Douglass Winthrop Advisors's 13F filing for Q1 2019, filed 9 Apr 2019.